title: Renal disease associated with antiretroviral therapy in the treatment of HIV.
abstract: The introduction of potent combination antiretroviral therapy (ART) in the treatment of HIV infection has permitted reliable control of disease progression and has markedly improved survival among people with HIV. As a result, health care providers and patients have shifted clinical priorities; whereas once delaying opportunistic illness was a primary focus, increasing emphasis is now placed on preventative health, management of comorbid chronic disease and avoiding long-term toxicities of ART. Although renal disease is common in people with HIV, renal disease specifically due to ART remains relatively rare. Still, as the use of ART continues to increase, health care providers are likely to encounter this potentially serious complication with increasing frequency. Distinguishing ART-related nephrotoxicity from the myriad of other potential causes of renal disease in people with HIV is important in order to avoid unnecessary discontinuation of an appropriate ART regimen. This review focuses on the early recognition of renal disease associated with ART and suggests strategies for management and prevention.
authors.affiliation: Department of Medicine, University of Alberta, Edmonton, Alta., Canada.
authors.forename: Ryan D
authors.initials: RD
authors.lastname: Cooper
authors.forename: Marcello
authors.initials: M
authors.lastname: Tonelli
mesh_terms: D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives; D044966:Anti-Retroviral Agents / Q000009:adverse effects*; D000069446:Atazanavir Sulfate; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019469:Indinavir / Q000009:adverse effects; D007674:Kidney Diseases / Q000139:chemically induced* / Q000175:diagnosis; D009842:Oligopeptides / Q000009:adverse effects; D063065:Organophosphonates / Q000009:adverse effects; D011725:Pyridines / Q000009:adverse effects; D000068698:Tenofovir
chemical_list: D044966:Anti-Retroviral Agents; D009842:Oligopeptides; D063065:Organophosphonates; D011725:Pyridines; D000069446:Atazanavir Sulfate; D019469:Indinavir; D000068698:Tenofovir; D000225:Adenine